Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
143.6 EUR | -0.28% |
|
+0.81% | +17.36% |
07-15 | Global markets live: Airbus, Burberry, AT&T, Boeing, Vinfast... | ![]() |
07-15 | AstraZeneca: acquisition of Amolyt Pharma finalized | CF |
Sales 2024 * | 51.62B 47.41B 3,985B | Sales 2025 * | 55.49B 50.97B 4,284B | Capitalization | 244B 224B 18,812B |
---|---|---|---|---|---|
Net income 2024 * | 8.73B 8.02B 674B | Net income 2025 * | 10.46B 9.61B 808B | EV / Sales 2024 * | 5.13 x |
Net Debt 2024 * | 20.99B 19.28B 1,621B | Net Debt 2025 * | 14.52B 13.34B 1,121B | EV / Sales 2025 * | 4.65 x |
P/E ratio 2024 * |
27.9
x | P/E ratio 2025 * |
23.2
x | Employees | 89,900 |
Yield 2024 * |
1.96% | Yield 2025 * |
2.07% | Free-Float | 96.64% |
Latest transcript on AstraZeneca PLC
1 day | -0.28% | ||
1 week | +0.81% | ||
Current month | -2.49% | ||
1 month | -3.38% | ||
3 months | +11.81% | ||
6 months | +16.31% | ||
Current year | +17.36% |
![Extreme 141.6](/images/extremecours_fleche.png)
![Extreme 141.45](/images/extremecours_fleche.png)
![Extreme 112.45](/images/extremecours_fleche.png)
![Extreme 112.45](/images/extremecours_fleche.png)
![Extreme 94](/images/extremecours_fleche.png)
![Extreme 64.57](/images/extremecours_fleche.png)
![Extreme 47.738](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 64 | 30/09/12 |
Aradhana Sarin
DFI | Director of Finance/CFO | 50 | 31/07/21 |
Sharon Barr
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sherilyn McCoy
BRD | Director/Board Member | 66 | 30/09/17 |
Philip Broadley
BRD | Director/Board Member | 63 | 26/04/17 |
Director/Board Member | 68 | 31/03/99 |
Date | Price | Change | Volume |
---|---|---|---|
16/07/24 | 143 | -0.73% | 20 |
15/07/24 | 144 | -1.64% | 586 |
12/07/24 | 146.4 | +0.45% | 450 |
11/07/24 | 145.8 | +1.82% | 90 |
10/07/24 | 143.2 | +0.95% | 2,085 |
Delayed Quote Deutsche Boerse AG, July 16, 2024 at 08:12 am
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.05% | 856B | |
+40.09% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+5.48% | 234B | |
+16.52% | 226B | |
+14.63% | 177B | |
+1.08% | 165B |
- Stock Market
- Equities
- AZN Stock
- ZEG Stock